Marketing services

Oriola and Merck Sharp & Dohme (MSD) have signed an agreement on the marketing and distribution of medicines in the Baltic countries. Under the agreement Oriola will distribute and market MSD human prescription products in Estonia, Lithuania and Latvia. MSD sales and marketing personnel in Estonia, Lithuania and Latvia will become employees of SIA Oriola Riga, AS Oriola and UAB Oriola Vilnius: in Lithuania as of 1 May 2013 and in Estonia and Latvia as of 9 May 2013. The distribution of MSD products to all Baltic countries will take place centrally from the warehouse of Oriola Vilnius as of September 2013. MSD will continue to be in charge of marketing authorisation and product strategy including market access, medical affairs and clinical research in the Baltic countries.

“The agreement with MSD is an important strategic step forward for Oriola and it will provide our business in the Baltic countries with a substantial boost. We are very pleased with the confidence MSD has shown in us and we are ready to offer our customers efficient logistics services and innovative Baltic-wide services.” Pekka Ruokanen, Director, Baltic countries.

“In a rapidly changing business environment we need to keep performing and transforming. MSD continues to seek ways to maximize business opportunities through strategic alliances with third parties to sharpen our focus and improve flexibility. We are pleased to announce Oriola as our partner of choice and look forward to building a successful collaboration with them,” says Ilpo Tolonen, Assoc. Vice President and Managing Director MSD Finland & Baltics.

MSD - Be well

Today's MSD is a global healthcare leader working to help the world be well.  MSD is known as Merck inside the United States and Canada. Through their prescription medicines, vaccines, biologic therapies, and consumer care and animal health products, MSD works with customers and operates in more than 140 countries to deliver innovative health solutions.  MSD also demonstrates their commitment to increasing access to healthcare through far-reaching policies, programs and partnerships.  For more information, visit www.msd.com and connect with MSD on Twitter, Facebook and YouTube.

 

Oriola – preferred partner for the pharmaceutical industry

Oriola’s vision is to be the preferred partner for the pharmaceutical industry. Oriola offers efficient logistics and innovative Baltic-wide services. SIA Oriola Riga, AS Oriola Estonia and UAB Oriola Vilnius are subsidiaries of the Finnish company Oriola Oy, which is a part of Oriola-KD Corporation. Oriola-KD Corporation is a leading company in pharmaceutical wholesale and retail in Finland, Sweden, and the Baltic countries. Oriola-KD’s net sales in 2014 were EUR 1.6 billion and the number of personnel was 2300. For more information, visit www.oriola-kd.com, www.oriola.lt, www.oriola.lv, www.oriola.ee.